These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7958055)

  • 1. Apraclonidine in the management of glaucomatocyclitic crisis.
    Muthusamy P
    Eye (Lond); 1994; 8 ( Pt 3)():367-8. PubMed ID: 7958055
    [No Abstract]   [Full Text] [Related]  

  • 2. Reversal of intraocular pressure increases with 0.5% apraclonidine after dilated fundus examination in patients with chronic open-angle glaucoma.
    Nishimoto JH; Chang FW; Tang IH; Kolin T
    J Am Optom Assoc; 1999 Apr; 70(4):233-9. PubMed ID: 10457699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Questions concerning the role of apraclonidine in the management of glaucoma.
    Robin AL
    Arch Ophthalmol; 1995 Jun; 113(6):712-4. PubMed ID: 7786208
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy of apraclonidine ophthalmic solution (iopidine) in presumed silicon oil-induced glaucoma and primary open-angle glaucoma.
    Flach AJ
    Surv Ophthalmol; 1995; 40(1):84-5. PubMed ID: 8545811
    [No Abstract]   [Full Text] [Related]  

  • 5. Topical apraclonidine hydrochloride in eyes with poorly controlled glaucoma. The Apraclonidine Maximum Tolerated Medical Therapy Study Group.
    Robin AL; Ritch R; Shin D; Smythe B; Mundorf T; Lehmann RP
    Trans Am Ophthalmol Soc; 1995; 93():421-38; discussion 439-41. PubMed ID: 8719690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The rarity of clinically significant rise in intraocular pressure after laser peripheral iridotomy with apraclonidine.
    Lewis R; Perkins TW; Gangnon R; Kaufman PL; Heatley GA
    Ophthalmology; 1998 Dec; 105(12):2256-9. PubMed ID: 9855156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of apraclonidine hydrochloride on the attack of Posner-Schlossman syndrome.
    Hong C; Song KY
    Korean J Ophthalmol; 1993 Jun; 7(1):28-33. PubMed ID: 7901442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apraclonidine prophylaxis for postcycloplegic intraocular pressure spikes.
    Hill RA; Minckler DS; Lee M; Heuer DK; Baerveldt G; Martone JF
    Ophthalmology; 1991 Jul; 98(7):1083-6. PubMed ID: 1679917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term clinical trial evaluating the efficacy of the combination of apraclonidine 0.5% solution and betaxolol 0.25% suspension.
    Lamberti G; Pignalosa B; Fusco R; Pignalosa G; Di Govanni A; Sebastiani A
    Acta Ophthalmol Scand Suppl; 1997; (224):20-1. PubMed ID: 9589713
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of apraclonidine on short-term outcome of glaucoma surgery.
    Azuara-Blanco A; Araujo SV; Lu DW; Lesk MR; Katz LJ; Spaeth GL
    J Glaucoma; 1996 Apr; 5(2):117-9. PubMed ID: 8795743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early intraocular pressure response to laser trabeculoplasty 180 degrees without apraclonidine versus 360 degrees with apraclonidine.
    Allf BE; Shields MB
    Ophthalmic Surg; 1991 Sep; 22(9):539-42. PubMed ID: 1682861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apraclonidine and argon laser trabeculoplasty.
    Holmwood PC; Chase RD; Krupin T; Rosenberg LF; Ruderman JM; Tallman BA; Brodstein DE; Chopra H; Goldenfeld M
    Am J Ophthalmol; 1992 Jul; 114(1):19-22. PubMed ID: 1352428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Reduction of ocular pulse amplitude by apraclonidine--prospective double-blind, randomized clinical trial with 10 subjects].
    Kuba GB; Austermann P
    Klin Monbl Augenheilkd; 2001 Mar; 218(3):187-91. PubMed ID: 11322056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New medical therapies for glaucoma.
    Drake MV
    Int Ophthalmol Clin; 1996; 36(2):53-60. PubMed ID: 8950633
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect and side effects of apraclonidine].
    Stewart WC
    Klin Monbl Augenheilkd; 1996 Jul; 209(1):A7-13. PubMed ID: 8965469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of intraocular pressure elevations after argon laser trabeculoplasty: comparison of brimonidine 0.2% to apraclonidine 1.0%.
    Barnes SD; Campagna JA; Dirks MS; Doe EA
    Ophthalmology; 1999 Oct; 106(10):2033-7. PubMed ID: 10519604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure of apraclonidine to prevent delayed IOP elevation after Nd:YAG laser posterior capsulotomy.
    Nesher R; Kolker AE
    Trans Am Ophthalmol Soc; 1990; 88():229-32; discussion 233-6. PubMed ID: 1982748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of apraclonidine hydrochloride in laser therapy for glaucoma.
    Robin AL
    Trans Am Ophthalmol Soc; 1989; 87():729-61. PubMed ID: 2562547
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of apraclonidine in long-term timolol users.
    Gharagozloo NZ; Brubaker RF
    Ophthalmology; 1991 Oct; 98(10):1543-6. PubMed ID: 1683697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of apraclonidine ophthalmic solution (Iopidine) in presumed silicon oil-induced glaucoma and primary open-angle glaucoma.
    Gramer E; Busche S; Kampik A; Parsons D
    Graefes Arch Clin Exp Ophthalmol; 1995 Jan; 233(1):13-20. PubMed ID: 7721118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.